Clinical Trials

NCT07686796 | NOT_YET_RECRUITING | PHASE3
148 participants

Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-07
Start Date:
2027-01-01
Completion:
2030-01-01
Conditions
  • Local Advanced Rectal Cancer
  • PD-1 Inhibitor
  • PCSK9 Inhibitor
  • RCT
  • Radiotherapy
  • Capecitabine
  • Oxaliplatin
Interventions
  • RADIATION
  • DRUG
No Results Yet
NCT07686731 | NOT_YET_RECRUITING | PHASE4
142 participants

Suvorexant 3 - PE-PC

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-07
Start Date:
2026-09-01
Completion:
2029-03-01
Conditions
  • PTSD - Post Traumatic Stress Disorder
  • Insomnia
  • TBI (Traumatic Brain Injury)
Interventions
  • DRUG
  • BEHAVIORAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page